☆ 4.6 Article

Development of ensemble learning models for prognosis of hepatocellular carcinoma patients underwent postoperative adjuvant transarterial chemoembolization

FRONTIERS IN ONCOLOGY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Oncology

CT texture analysis in predicting treatment response and survival in patients with hepatocellular carcinoma treated with transarterial chemoembolization using random forest models

He An et al.

Summary: This study used texture features derived from contrast-enhanced CT, general imaging features, and clinical information to predict treatment response and survival in HCC patients treated with TACE. The results showed that the random forest algorithm based on texture features, combined with general imaging features and clinical information, can effectively predict prognosis in HCC patients.

BMC CANCER (2023)

添加到收藏夹

Article Immunology

T-cell exhaustion signatures characterize the immune landscape and predict HCC prognosis via integrating single-cell RNA-seq and bulk RNA-sequencing

Hao Chi et al.

Summary: A TEX-based signature was developed using single-cell RNA-seq and high-throughput RNA sequencing to evaluate the prognosis and immunotherapeutic response of HCC patients. The study found that TEX genes were closely associated with HCC prognosis, and patients in the low-risk group had a better overall survival rate. This study provides a new method for assessing immune therapy efficacy and has important implications for future precision immuno-oncology studies.

FRONTIERS IN IMMUNOLOGY (2023)

添加到收藏夹

Review Gastroenterology & Hepatology

Treatment and the prognosis of hepatocellular carcinoma in Asia

Takuji Torimura et al.

Summary: Hepatocellular carcinoma is the most common malignant tumor in Asia, and treatment methods are determined based on tumor staging and liver function. Treatment guidelines in Asian countries are generally more aggressive and include combination therapies and alternative treatments. Molecular targeted agents, antibodies, and immune checkpoint inhibitors have been used for the treatment of hepatocellular carcinoma. Taiwan and Japan have the best clinical outcomes for patients with hepatocellular carcinoma.

LIVER INTERNATIONAL (2022)

添加到收藏夹

Article Oncology

Preoperative Prognostic Nutritional Index and Neutrophil-to-Lymphocyte Ratio Predict Survival Outcomes of Patients With Hepatocellular Carcinoma After Curative Resection

Zhen Qu et al.

Summary: This study analyzed the data of 215 patients who underwent curative resection for hepatocellular carcinoma (HCC) and found that prognostic nutritional index (PNI) and neutrophil-to-lymphocyte ratio (NLR) were independent prognostic factors for overall survival and recurrence-free survival. A new nomogram based on PNI and NLR may provide individualized predictions of survival and recurrence for HCC patients.

FRONTIERS IN ONCOLOGY (2022)

添加到收藏夹

Review Gastroenterology & Hepatology

Artificial intelligence for the prevention and clinical management of hepatocellular carcinoma

Julien Calderaro et al.

Summary: Hepatocellular carcinoma (HCC) is a growing malignancy with increasing incidence and mortality rates globally. Artificial intelligence (AI) provides a unique opportunity to enhance HCC risk prediction, diagnosis, and prognostication. Machine learning (ML) and deep learning (DL) models, applied to diverse data sources, have shown promising results in improving accuracy of HCC risk prediction, detection, and treatment response prediction. However, further research is needed to address challenges related to standardizing AI data and ensuring interpretability of results.

JOURNAL OF HEPATOLOGY (2022)

添加到收藏夹

Article Oncology

Ensemble learning based on efficient features combination can predict the outcome of recurrence-free survival in patients with hepatocellular carcinoma within three years after surgery

Liyang Wang et al.

Summary: This study proposes a machine learning-based method to predict the recurrence outcome of hepatocellular carcinoma patients within three years after surgery by analyzing preoperative imaging and clinical data. The results show that the method can relatively accurately predict recurrence and assist physicians in evaluating patients before surgery.

FRONTIERS IN ONCOLOGY (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Prognostic Nutritional Index and Systemic Immune-Inflammation Index Predict the Prognosis of Patients with HCC

Dong Wang et al.

Summary: This study found that PNI and SII could be important prognostic parameters for HCC patients who underwent hepatectomy.

JOURNAL OF GASTROINTESTINAL SURGERY (2021)

添加到收藏夹

Article Surgery

The Preoperative Prognostic Nutritional Index in Hepatocellular Carcinoma After Curative Hepatectomy: A Retrospective Cohort Study and Meta-Analysis

Xiaoxiao Fan et al.

Summary: The study demonstrated that a low preoperative PNI was associated with poor recurrence-free survival in HCC patients after hepatectomy. Furthermore, a low PNI was found to be an independent prognostic factor for overall survival and recurrence-free survival rates in HCC patients, especially those with TNM stage I. The pooled analysis also indicated a significant association between low PNI and poor overall survival and recurrence-free survival rates.

JOURNAL OF INVESTIGATIVE SURGERY (2021)

添加到收藏夹

Article Surgery

Repeated postoperative adjuvant TACE after curative hepatectomy improves outcomes of patients with HCC

A. Lei Feng et al.

Summary: The study shows that postoperative adjuvant TACE treatment for HCC may delay tumor recurrence and improve relapse-free survival rates after curative hepatectomy.

MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Exploring prognostic indicators in the pathological images of hepatocellular carcinoma based on deep learning

Jie-Yi Shi et al.

Summary: The study proposed a deep learning framework for analysing hepatocellular carcinoma (HCC) pathological images and exploring new prognostic phenotypes. Through TRS scoring and risk activation mapping, it effectively evaluated patient outcomes and identified the main underlying features of TRS. The results showed that TRS is an independent prognosticator superior to clinical staging systems.

GUT (2021)

添加到收藏夹

Article Medicine, General & Internal

Hepatocellular carcinoma

Josep M. Llovet et al.

Summary: Liver cancer, particularly hepatocellular carcinoma (HCC), poses a significant global health challenge with rising incidence projected to exceed 1 million cases by 2025. Infection by hepatitis B and C viruses remains a major risk factor for HCC, while non-alcoholic steatohepatitis is emerging as a more common risk factor in Western countries. Advances in systemic therapies for HCC, including immunotherapies and targeted therapies, are expected to revolutionize the management of this disease.

NATURE REVIEWS DISEASE PRIMERS (2021)

添加到收藏夹

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

添加到收藏夹

Review Oncology

The effects of several postoperative adjuvant therapies for hepatocellular carcinoma patients with microvascular invasion after curative resection: a systematic review and meta-analysis

Jiarui Yang et al.

Summary: pa-TACE, postoperative radiotherapy, and sorafenib can improve the prognosis of patients with hepatocellular carcinoma with microvascular invasion after curative resection compared to postoperative conservative treatment. Postoperative radiotherapy can reduce the recurrence of patients with HCC with MVI after curative resection when compared to pa-TACE.

CANCER CELL INTERNATIONAL (2021)

添加到收藏夹

Article Oncology

Development and Validation of a Machine Learning Prognostic Model for Hepatocellular Carcinoma Recurrence After Surgical Resection

Yao Huang et al.

Summary: A machine learning prognostic model was developed to identify high-risk patients after surgical resection, with variable importance reviewed in different time intervals. Tumor characteristics contribute more to HCC relapse in 0 to 1 year, while HBV infection and smoking largely affect patients' outcome in 3 to 5 years.

FRONTIERS IN ONCOLOGY (2021)

添加到收藏夹

Article Oncology

Prediction of Early Recurrence After Surgery for Liver Tumor (ERASL): An International Validation of the ERASL Risk Models

Berend R. Beumer et al.

Summary: The international cohort study found that the ERASL models had lower discriminatory power for Western patients compared to Japanese patients, and recalibration was needed to improve prediction accuracy. A model specifically tailored for Western patients or explaining the East-West difference is still necessary to be developed.

ANNALS OF SURGICAL ONCOLOGY (2021)

添加到收藏夹

Article Oncology

Transarterial chemoembolization versus best supportive care for patients with hepatocellular carcinoma with portal vein tumor thrombus : a multicenter study

Xiao Xiang et al.

EJSO (2019)

添加到收藏夹

Review Medicine, General & Internal

Hepatocellular Carcinoma

Augusto Villanueva

NEW ENGLAND JOURNAL OF MEDICINE (2019)

添加到收藏夹

Article Oncology

CRP/prealbumin, a novel inflammatory index for predicting recurrence after radical resection in gastric cancer patients: post hoc analysis of a randomized phase III trial

Jun Lu et al.

GASTRIC CANCER (2019)

添加到收藏夹

Letter Medicine, General & Internal

Machine Learning in Medicine

Ben Van Calster et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

添加到收藏夹

Article Gastroenterology & Hepatology

AASLD guidelines for the treatment of hepatocellular carcinoma

Julie K. Heimbach et al.

HEPATOLOGY (2018)

添加到收藏夹

Article Oncology

Critical evaluation of the American Joint Commission on Cancer (AJCC) 8th edition staging system for patients with Hepatocellular Carcinoma (HCC): A Surveillance, Epidemiology, End Results (SEER) analysis

Sivesh K. Kamarajah et al.

JOURNAL OF SURGICAL ONCOLOGY (2018)

添加到收藏夹

Article Health Care Sciences & Services

DeepSurv: personalized treatment recommender system using a Cox proportional hazards deep neural network

Jared L. Katzman et al.

BMC MEDICAL RESEARCH METHODOLOGY (2018)

添加到收藏夹

Review Biochemistry & Molecular Biology

Next-Generation Machine Learning for Biological Networks

Diogo M. Camacho et al.

CELL (2018)

添加到收藏夹

Review Medicine, General & Internal

Hepatocellular carcinoma

Alejandro Forner et al.

LANCET (2018)

添加到收藏夹

Article Medicine, General & Internal

The High-Sensitivity C-Reactive Protein/Albumin Ratio Predicts Long-Term Oncologic Outcomes after Curative Resection for Hepatocellular Carcinoma

Tak Kyu Oh et al.

JOURNAL OF CLINICAL MEDICINE (2018)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Preoperative high-sensitivity C-reactive protein to lymphocyte ratio index plays a vital role in the prognosis of hepatocellular carcinoma after surgical resection

Minjun Liao et al.

ONCOTARGETS AND THERAPY (2018)

添加到收藏夹

Review Gastroenterology & Hepatology

Prognostic Role of Platelet-to-Lymphocyte Ratio in Hepatocellular Carcinoma with Different BCLC Stages: A Systematic Review and Meta-Analysis

Wan-fu Lin et al.

GASTROENTEROLOGY RESEARCH AND PRACTICE (2018)

添加到收藏夹

Review Gastroenterology & Hepatology

Carcinogenesis on the background of liver fibrosis: Implications for the management of hepatocellular cancer

Joanne Marie O'Rourke et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2018)

添加到收藏夹

Article Health Care Sciences & Services

Predictive accuracy of novel risk factors and markers: A simulation study of the sensitivity of different performance measures for the Cox proportional hazards regression model

Peter C. Austin et al.

STATISTICAL METHODS IN MEDICAL RESEARCH (2017)

添加到收藏夹

Article Gastroenterology & Hepatology

Development of Risk Prediction Model for Hepatocellular Carcinoma Progression of Indeterminate Nodules in Hepatitis B Virus-Related Cirrhotic Liver

Hyo Jung Cho et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2017)

添加到收藏夹

Review Oncology

Liver immunotolerance and hepatocellular carcinoma: Patho-physiological mechanisms and therapeutic perspectives

Gael S. Roth et al.

EUROPEAN JOURNAL OF CANCER (2017)

添加到收藏夹

Article Gastroenterology & Hepatology

Development and validation of the HALT-HCC score to predict mortality in liver transplant recipients with hepatocellular carcinoma: a retrospective cohort analysis

Kazunari Sasaki et al.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2017)

添加到收藏夹

Article

Transcatheter Arterial Chemoembolization Combined with Interferon-α is Safe and Effective for Patients with Hepatocellular Carcinoma after Curative Resection

Chaohui Zuo et al.

Asian Pacific Journal of Cancer Prevention (2015)

添加到收藏夹

Article Oncology

Inflammation and cancer: advances and new agents

Shanthini M. Crusz et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2015)

添加到收藏夹

Article Multidisciplinary Sciences

The Singapore Liver Cancer Recurrence (SLICER) Score for Relapse Prediction in Patients with Surgically Resected Hepatocellular Carcinoma

Soo Fan Ang et al.

PLOS ONE (2015)

添加到收藏夹

Article Gastroenterology & Hepatology

Adjuvant transarterial chemoembolization after curative resection of hepatocellular carcinoma: Propensity score analysis

Jing-Hang Jiang et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2015)

添加到收藏夹

Article Multidisciplinary Sciences

Establishment and Validation of SSCLIP Scoring System to Estimate Survival in Hepatocellular Carcinoma Patients Who Received Curative Liver Resection

Sha Huang et al.

PLOS ONE (2015)

添加到收藏夹

Review Gastroenterology & Hepatology

Recent advances in multidisciplinary management of hepatocellular carcinoma

Asmaa I. Gomaa et al.

WORLD JOURNAL OF HEPATOLOGY (2015)

添加到收藏夹

Article Oncology

Long-Term Outcomes and Prognostic Factors with Reductive Hepatectomy and Sequential Percutaneous Isolated Hepatic Perfusion for Multiple Bilobar Hepatocellular Carcinoma

Takumi Fukumoto et al.

ANNALS OF SURGICAL ONCOLOGY (2014)

添加到收藏夹

Article Oncology

Systemic Immune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular Carcinoma

Bo Hu et al.

CLINICAL CANCER RESEARCH (2014)

添加到收藏夹

Article Gastroenterology & Hepatology

Hepatocellular carcinoma: clinical frontiers and perspectives

Jordi Bruix et al.

GUT (2014)

添加到收藏夹

Article Gastroenterology & Hepatology

Machine Learning Algorithms Outperform Conventional Regression Models in Predicting Development of Hepatocellular Carcinoma

Amit G. Singal et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)

添加到收藏夹

Article Multidisciplinary Sciences

Adjuvant Iodine-125 Brachytherapy for Hepatocellular Carcinoma after Complete Hepatectomy: A Randomized Controlled Trial

Kaiyun Chen et al.

PLOS ONE (2013)

添加到收藏夹

Article Oncology

High-Sensitivity C-Reactive Protein Levels and Cancer Mortality

Young-Jin Ko et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2012)

添加到收藏夹

Article Surgery

Microvascular Invasion Is a Better Predictor of Tumor Recurrence and Overall Survival Following Surgical Resection for Hepatocellular Carcinoma Compared to the Milan Criteria

Kheng-Choon Lim et al.

ANNALS OF SURGERY (2011)

添加到收藏夹

Review Gastroenterology & Hepatology

Postoperative adjuvant transarterial chemoembolization for participants with hepatocellular carcinoma: A meta-analysis

Jian-Hong Zhong et al.

HEPATOLOGY RESEARCH (2010)

添加到收藏夹

Article Surgery

Adjuvant transcatheter arterial chemoembolization improves efficacy of hepatectomy for patients with hepatocellular carcinoma and portal vein tumor thrombus

Bao-Gang Peng et al.

AMERICAN JOURNAL OF SURGERY (2009)

添加到收藏夹

Article Gastroenterology & Hepatology

A System of Classifying Microvascular Invasion to Predict Outcome After Resection in Patients With Hepatocellular Carcinoma

Sasan Roayaie et al.

GASTROENTEROLOGY (2009)

添加到收藏夹

Article Oncology

A randomized controlled trial of hepatectomy with adjuvant transcatheter arterial chemoembolization versus hepatectomy alone for Stage III A hepatocellular carcinoma

Chong Zhong et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2009)

添加到收藏夹

Article Oncology

Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection

Qiang Gao et al.

JOURNAL OF CLINICAL ONCOLOGY (2007)

添加到收藏夹

Review Gastroenterology & Hepatology

Management of hepatoceullular carcinoma

J Bruix et al.

HEPATOLOGY (2005)

添加到收藏夹

Review Multidisciplinary Sciences

Inflammation and cancer

LM Coussens et al.

NATURE (2002)

添加到收藏夹

Article Gastroenterology & Hepatology

Prognostic prediction and treatment strategy in hepatocellular carcinoma

J Bruix et al.

HEPATOLOGY (2002)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.